Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis-Reference-Cited by-同舟云学术

Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis

Published:2024-03-14 Issue:4 Volume:7 Page:1126-1141
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Deng Bochuan¹^ORCID,Zhang Jiao¹,Zhang Xiang¹,Wang Dan²,Cheng Lu³,Su Ping¹,Yu Tingli¹,Bao Guangjun¹,Li Guofeng⁴^ORCID,Hong Liang⁵^ORCID,Miao Xiaokang¹,Yang Wenle¹,Wang Rui¹⁶^ORCID,Xie Junqiu¹^ORCID

Affiliation:

1. Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou 730000, China

2. Medical Imaging Key Laboratory of Sichuan Province, North Sichuan Medical College, Nanchong 637000, China

3. School of Biomedical Engineering, Shenzhen University Health Science Centre, Shenzhen University, Shenzhen 518060, China

4. School of Pharmaceutical Sciences, Shenzhen University Health Science Centre, Shenzhen University, Shenzhen 518060, China

5. Guangdong Provincial Key Laboratory of Chiral Molecular and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China

6. Institute of Materia Medica and Research Unit of Peptide Science, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

Funder

Ministry of Education of the People's Republic of China

Chinese Academy of Medical Sciences

Science and Technology Program of Gansu Province

Fundamental Research Funds for the Central Universities

Guangdong Provincial Key Laboratory of Construction Foundation

Doctoral Scientific Research Fund of North Sichuan Medical College

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.4c00010

Reference51 articles.

1. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

2. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories

4. Decoding myofibroblast origins in human kidney fibrosis

5. TGF-β: the master regulator of fibrosis